课题基金 / 基金详情

Advancing equitable implementation of genomic medicine in nephrology

Advancing equitable implementation of genomic medicine in nephrology
促进基因组医学在肾病学领域的公平实施
批准号:
10701851
负责人:
Hila Milo Rasouly
金额:
$12.92万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-15 至 2027-08-31
关键词:
AccelerationAddressAdoptionCharacteristicsChronic Kidney FailureClinicClinicalCollaborationsCommunication ResearchCommunitiesCompetenceDataDevelopmentDissemination and ImplementationDoctor of PhilosophyEducational StatusEnsureEnvironmentEquityEthnic OriginFeasibility StudiesFoundationsFundingFutureGenesGeneticGenetic CounselingGenetic DeterminismGenomic medicineGenomicsGoalsGrantGuidelinesHealth educationHealthcare SystemsHigh PrevalenceInternationalInterventionInterviewInvestmentsKidneyKidney DiseasesKnowledgeLeadLearningMeasuresMedical GeneticsMentored Research Scientist Development AwardMentorsMentorshipMethodsNational Institute of Diabetes and Digestive and Kidney DiseasesNephrologyOnline SystemsOutcomeParticipantPathologyPatientsPopulationProspective StudiesProviderQualitative ResearchRaceRecommendationResearchResearch MethodologyResearch PersonnelResearch PriorityResearch TrainingResourcesRespondentStrategic PlanningSurveysTestingTrainingTranslatingUnited States National Institutes of HealthUniversitiesarmclinical careclinical practicecohortcomputer human interactiondesignefficacy trialethical, legal, and social implicationethnic minorityexperiencefeasibility testingfuture implementationgenetic counselorgenetic disorder diagnosisgenetic testinghealth communicationhealth disparityhealth equityhealth literacyimplementation frameworkimplementation researchimplementation scienceimplementation strategyimprovedinnovationkidney biopsyliteracymarginalizationnovelpatient engagementpatient screeningpersonalized carepilot testpoint of carepost-doctoral trainingpractice settingpragmatic studyprecision medicinepreventprogramsprospectivepublic health relevanceracial minorityscreeningsecondary outcomeskillssocial determinantssocioeconomicsstatisticsstructural determinantssymposiumtheoriestooltranslational geneticstranslational genomicsuptake

项目摘要

项目成果

Hila Milo Rasouly的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is an immense national investment in Precision Medicine, however fulfillment of its promises depends on broad utilization of genetic testing among nephrologists and patients, many of whom are from marginalized racial/ethnic minorities. Research demonstrates that genetic forms of kidney disease are relatively prevalent, and their identification can personalize care, yet genetic testing is not part of standard clinical care in nephrology. This K01 proposes to identify the barriers to genetic testing in nephrology at the patient, clinician, and healthcare system levels, and to develop and test possible facilitators. I will use a mixed methods design to collect nuanced, currently unavailable, data on these issues with the goal of informing future implementation guidelines. Aim 1 will assess the rate of adoption of genetic testing in nephrology, and the barriers, facilitators, and acceptability of potential implementation strategies to accelerate the adoption of genetic testing in nephrology. To address the low confidence of nephrologists in genetics—a key barrier in effort to translate knowledge from labs to the clinics—in Aim 2, I will use participatory design to develop a toolbox with the input of both patients and nephrologists. The toolbox will include (i) a self-paced course in clinical renal genetics and external resources, (ii) patient-facing materials with infographics, and (iii) a genetic literacy screen for patients. In Aim 3, I will assess the toolbox’s potential by pilot testing it with nephrologists. This K01 will inform future efficacy trials and lay the foundations for future research on interventions to ensure equitable access to genetic testing. Candidate: I hold a Master in Genetic Counseling, a PhD in genetics and genomics and have a post-doctoral training in renal genomics. To advance the implementation of genomic medicine in nephrology, there is a need for researchers with combined expertise in genetics, nephrology, implementation science, health communication, health equity research, and ethical, legal, and social Implications (ELSI) of genomics. My goal is to develop an independent research program focusing on the novel field of “equitable implementation of genomic medicine in nephrology”. During the K01’s training period, I will: (1) Develop expertise in the theoretical frameworks in implementation science, (2) Become proficient in ELSI and health equity research, (3) Develop expertise in qualitative research methods, (4) Refine my expertise in survey design, (5) Learn health communication research tools and (6) Transition to independence. Environment: To guide and support my research and training goals, I have assembled a strong mentorship team of experts in nephrology and renal genetics (Dr Gharavi, primary mentor), translation of genomics research into clinical practice (Dr Rahm, co-mentor), implementation science (Dr Moise, co-mentor), Equity and ELSI research (Dr Sabatello, co-mentor), health communication and infographics (Dr Bakken, Advisor), and statistics (Dr Ionita-Laza, Advisor). The research will be conducted at Columbia University, which will give me access to extensive research resources and training to help me successfully transition to independence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancing equitable implementation of genomic medicine in nephrology
海外基金